No Data
No Data
Silexion Therapeutics Stock Surges 52% On Catalent Collaboration For Cancer Therapy
12 Health Care Stocks Moving In Wednesday's Intraday Session
Silexion Therapeutics Collaborates With Catalent On Advanced SiRNA Formulation Development & Clinical Manufacturing Activities
Express News | Silexion Therapeutics Announces Collaboration With Global Therapeutics Leader Catalent on Advanced Sirna Formulation Development & Clinical Manufacturing Activities
Retail Buyers vs. Global Sellers: Is Now the Time to Jump into U.S. Stocks?
Trump's Tariff Backtrack: Tech Giants Set to Surge—Is It Time to Buy?